During the past decade, Neurologie und Psychiatrie / Psychotherapie conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Neurologie und Psychiatrie / Psychotherapie" are "Alzheimer Disease" (2 trials), "Schizophrenia" (2 trials), "Back Pain" (1 trials) and "Neck Pain" (1 trials). Many other conditions were trialed in "Neurologie und Psychiatrie / Psychotherapie" in a lesser frequency.

Most popular intervention types in "Neurologie und Psychiatrie / Psychotherapie" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "BI 409306" (2 trials), "BI 425809 dose 1" (1 trials), "BI 425809 dose 2" (1 trials) and "BI 425809 dose 3" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurologie und Psychiatrie / Psychotherapie" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Neurologie und Psychiatrie / Psychotherapie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Neurologie und Psychiatrie / Psychotherapie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Neurologie und Psychiatrie / Psychotherapie, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".